Here's why the Avita Medical share price is tumbling 20% today

Shares in the healthcare company are tanking today, despite no fresh news out since last week.

| More on:
A man sits uncomfortably at his laptop computer in an outdoor location at a table with trees in the background as he clutches the back of his neck with a wincing look on his face.

Image source: Getty Images

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

Key points

  • Avita Medical shares have copped a pounding today, down close to 20%
  • The dual-listed company released an update last Friday, but ASX investors seemed to be far more forgiving back then
  • It seems ASX investors might be following Avita's less-forgiving US investors today

It's been a fairly lacklustre start to the trading week for most ASX shares so far this Monday. At the time of writing, the All Ordinaries Index (ASX: XAO) has fallen by 0.21%. But let's talk about the plunging Avita Medical Inc. (ASX: AVH) share price.

Avita Medical shares are in freefall today. This ASX healthcare share has dropped by a precipitous 19.38% so far this Monday to $3.66 a share. That comes after Avita shares closed at $4.54 each last Friday.

It was even worse for Avita this morning too, with the shares hitting a low of $3.53 soon after market open. That was a drop of 22.25% at the time.

So what on earth is going on with Avita shares today that has this company losing so much value?

Why has the Avita Medical share price lost 20% today?

Well, Avita is a bit of a unique case on the ASX. The company is actually a dual-listed share, with its other listing being on the United States NASDAQ exchange – Avita Medical Inc. (NASDAQ: RCEL).

Last Friday, Avita released some financial results and guidance to investors, covering the three months to 31 March 2023. These results revealed a 40% increase in revenue for the quarter to $10.6 million, as well as a rise in gross profit margins to 84%.

The company also announced a major change in its leadership team. Chief commercial officer Erin Liberto has resigned from the company, while Terry Bromley and Debbie Gardener have been promoted to senior vice president of global sales, and senior vice president of global marketing and strategy respectively.

ASX investors reacted negatively to this news on Friday's session, sending Avita shares down by 5.42%.

But Avita's American investors were far more savage on Friday night (our time). Over on the NASDAQ, the Avita share price tanked by a nasty 22.94%.

It seems Avita's ASX investors might be taking a lead from their American counterparts today in the wake of Friday's far more savage reaction. This could explain the doubling down of selling pressure that we seem to be witnessing on the ASX today.

But shareholders arguably don't have too much to complain about. Even after today's savage selling, the Avita share price on the ASX is still up a whopping 90% in 2023 so far:

Motley Fool contributor Sebastian Bowen has no position in any of the stocks mentioned. The Motley Fool Australia's parent company Motley Fool Holdings Inc. has positions in and has recommended Avita Medical. The Motley Fool Australia has recommended Avita Medical. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.

More on Healthcare Shares

smiling health care workers in a medical setting
Healthcare Shares

'Critical unmet need': Why everyone is talking about this ASX 200 healthcare stock

This healthcare stock has been given a boost from the US FDA today.

Read more »

Senior woman with caregiver in the garden
Healthcare Shares

Why this ASX 200 stock is a retiree's dream

I think this is a very healthy and resilient stock.

Read more »

A doctor appears shocked as he looks through binoculars on a blue background.
Healthcare Shares

3 ASX 200 healthcare stocks that could deliver big returns for investors

Analysts see a lot of value in these stocks at current levels.

Read more »

A team of people giving the thumbs up sign representing APA and Wesfarmers doing a deal to study green hydrogen transport using an APA gas pipeline
Healthcare Shares

Why are so many top fundies overweight on CSL shares?

This is a healthy opportunity, according to a number of fund managers.

Read more »

Scientist looking at a laptop thinking about the share price performance.
Share Fallers

Why did this ASX All Ords stock just crash 16%?

Investors are punishing this ASX All Ords stock on Thursday. But why?

Read more »

woman in lab coat conducting testing representing biotech
Healthcare Shares

Can the CSL share price really reach $500 in just 3 years?

Leading analysts are expecting big returns from CSL shares in the months ahead.

Read more »

Two businesspeople walk together in an office, smiling as they enjoy a good business relationship.
Healthcare Shares

Why two brokers have named this ASX 200 stock as a best buy

Investors may want to pounce on this high-quality stock before it's too late.

Read more »

A young man goes over his finances and investment portfolio at home.
Healthcare Shares

What could $5,000 invested in CSL shares become in 1 year?

Let's see what sort of returns analysts are tipping for this ASX giant.

Read more »